INSIGHTS ON SOLID DOSE MANUFACTURING

SOLID DOSE MANUFACTURING SOLUTIONS

  • This high-output, vacuum drum commercial platform forms part of our Evolve range, designed to fill blister strips at high-speed. This unit offers a commercial scale-up from our vacuum drum development platform.

  • Used O'Hara LabCoat bench-top coating pan, model LABCOAT BT, stainless steel product contact surfaces, with 8.5" perforated pan with plenum, spray guns with Watson Marlow peristaltic pump system, on board air handling system, electrically heated, Siemens controls, 220 volt, 1 phase, 60 hertz, serial# 414, built 2015.

  • Mettler XS204 Powder Weighing Enclosure designed to provide personnel protection when working with powdered substances down to a respiratory exposure concentration of less than 1 microgram powder per cubic meter of air (<1 ug/m3). Design accommodates sufficient space for efficient, ergonomic execution of powder weighing operations utilizing the Mettler XS204 Analytical Balance with dimensions (DxHxW) of 17.84” x 12.67” x 10.35” [453mm x 322mm x 263mm].

  • Natoli Engineering is quickly becoming the leader in R&D tablet presses with this next-generation rotary tablet press. Designed to help solve formulation and scale-up challenges, the NP-RD30 rotary R&D tablet press replicates the design and functionality of a production press. The turret velocity of the NP-RD30 can reach that of production presses, meaning dwell time can be more accurately established during research and development.

  • Partner with Natoli Scientific during the earliest stages. Our scientific expertise with state-of-the-art analytical capabilities is ready to take any preformulation challenge.

    Natoli scientific has an expertise of handling a wide range of APIs for the development of oral solids. We apply principles of ‘Quality by Design’ to define Critical Material Attributes (CMA), Critical Process Parameters (CPP), Critical Quality Attributes (CQA) and Quality Target Product Profiles (QTPP). Because we believe that understanding material and process as much as possible in the early life cycle of drug product development program is an insurance for further development path. Keeping your practices up to date with the ICHQ8 regulatory guidance issued by the US FDA. This is also a gate way for a smooth ride of product in the different stages of product development stages.